Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Progressive multifocal leukoencephalopathy.

Alstadhaug KB, Myhr KM, Rinaldo CH.

Tidsskr Nor Laegeforen. 2017 Dec 12;137(23-24). doi: 10.4045/tidsskr.16.1092. Print 2017 Dec 12. Review. English, Norwegian.

2.
3.

Natalizumab-related PML 2 weeks after negative anti-JCV antibody assay.

Gagne Brosseau MS, Stobbe G, Wundes A.

Neurology. 2016 Feb 2;86(5):484-6. doi: 10.1212/WNL.0000000000002330. Epub 2016 Jan 6. No abstract available.

PMID:
26740679
4.

[Natalizumab can induce progressive multifocal leucoencephalopathy].

Theódórsdóttir A, Blaabjerg M, Falah M.

Ugeskr Laeger. 2014 Aug 25;176(35). pii: V03140165. Danish.

PMID:
25293706
5.

[Progressive multifocal leukoencephalopathy in a patient with multiple myeloma].

Willert CB, Engsig FN, Eskildsen HW, Andersen AB.

Ugeskr Laeger. 2014 Dec 1;176(49). pii: V08140432. Danish.

PMID:
25497861
6.
7.

New insights into progressive multifocal leukoencephalopathy.

Koralnik IJ.

Curr Opin Neurol. 2004 Jun;17(3):365-70. Review.

PMID:
15167073
8.

Progressive Multifocal Leukoencephalopathy Following Treatment with Rituximab in an HIV-Negative Patient with Non-Hodgkin Lymphoma. A Case Report and Literature Review.

Felli V, Di Sibio A, Anselmi M, Gennarelli A, Sucapane P, Splendiani A, Catalucci A, Marini C, Gallucci M.

Neuroradiol J. 2014 Dec;27(6):657-64. doi: 10.15274/NRJ-2014-10087. Epub 2014 Dec 1. Review.

9.

[Progressive multifocal leukoencephalopathy an chronic lymphocytic leukemia].

Attout H, Rahmeh F, Lehuede G, Girardel M, Ziegler F.

Rev Med Interne. 2000 Aug;21(8):698-700. French.

PMID:
10989496
10.

Longitudinal JCV serology in multiple sclerosis patients preceding natalizumab-associated progressive multifocal leukoencephalopathy.

Vennegoor A, van Rossum JA, Polman CH, Wattjes MP, Killestein J.

Mult Scler. 2015 Oct;21(12):1600-3. doi: 10.1177/1352458514567728. Epub 2015 Feb 6.

PMID:
25662344
11.

The effect of plasma exchange on serum anti-JC virus antibodies.

Subramanyam M, Plavina T, Khatri BO, Fox RJ, Goelz SE.

Mult Scler. 2013 Jun;19(7):912-9. doi: 10.1177/1352458512467502. Epub 2012 Dec 11.

PMID:
23232602
13.

Progressive multifocal leukoencephalopathy masquerading as cerebellar infarction.

Willott RH, Sunman W, Munshi SK.

Age Ageing. 2016 Jul;45(4):564-5. doi: 10.1093/ageing/afw052. Epub 2016 Apr 7.

PMID:
27056083
14.

[Progressive multifocal leukoencephalopathy].

Wakutani Y, Araga S, Nakano T, Nakashima K, Ohama E.

Nihon Rinsho. 2004 Jan;62 Suppl:308-11. Review. Japanese. No abstract available.

PMID:
15011372
15.

JC virus antibody and viremia as predictors of progressive multifocal leukoencephalopathy in human immunodeficiency virus-1-infected individuals.

Viscidi RP, Khanna N, Tan CS, Li X, Jacobson L, Clifford DB, Nath A, Margolick JB, Shah KV, Hirsch HH, Koralnik IJ.

Clin Infect Dis. 2011 Oct;53(7):711-5. doi: 10.1093/cid/cir507. Epub 2011 Aug 18.

16.
17.

Progressive multifocal leukoencephalopathy in a patient with multiple myeloma.

Akiyama M, Takahashi T, Nomura S, Yamashita Y, Hatao K.

Int J Hematol. 2010 Jul;92(1):186-9. doi: 10.1007/s12185-010-0600-2. Epub 2010 May 28.

PMID:
20506049
18.

[Progressive multifocal leukoencephalopathy confirmed by PCR for JC virus in cerebrospinal fluid: case report].

Pasqualotto AC, de Mattos AJ, Rocha MM.

Arq Neuropsiquiatr. 2004 Jun;62(2B):550-4. Epub 2004 Jul 20. Review. Portuguese.

19.

JCV-negative natalizumab-associated progressive multifocal leukoencephalopathy: a clinico-radiological diagnosis.

Travasarou M, Marousi S, Papageorgiou E, Karageorgiou CE.

Clin Neurol Neurosurg. 2013 Jun;115(6):827-9. doi: 10.1016/j.clineuro.2012.08.013. Epub 2012 Aug 21. No abstract available.

PMID:
22920632
20.

Molecular diagnostic tests to predict the risk of progressive multifocal leukoencephalopathy in natalizumab-treated multiple sclerosis patients.

Rossi F, Newsome SD, Viscidi R.

Mol Cell Probes. 2015 Feb;29(1):54-62. doi: 10.1016/j.mcp.2014.11.007. Epub 2014 Dec 5. Review.

PMID:
25483260

Supplemental Content

Support Center